CASGEVY

This brand name is authorized in United States. It is also authorized in Croatia, Lithuania, UK.

Active ingredients

The drug CASGEVY contains one active pharmaceutical ingredient (API):

1
UNII S53L777GM8 - EXAGAMGLOGENE AUTOTEMCEL
 

Exagamglogene autotemcel is a cell therapy consisting of autologous CD34+ HSPCs ex vivo edited by CRISPR/Cas9-technology. The highly specific guide RNA enables CRISPR/Cas9 to make a precise DNA double-strand break at the critical transcription factor binding site (GATA1) in the erythroid specific enhancer region of the BCL11A gene. As a result of the editing, GATA1 binding is irreversibly disrupted and BCL11A expression reduced. Reduced BCL11A expression results in an increase in γ-globin expression and foetal haemoglobin (HbF) protein production in erythroid cells, addressing the absent globin in transfusion-dependent β-thalassemia (TDT) and the aberrant globin in sickle cell disease (SCD), which are the underlying causes of disease.

 
Read more about Exagamglogene autotemcel

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 CASGEVY Dispersion for infusion MPI, EU: SmPC European Medicines Agency (EU)
 CASGEVY Suspension for infusion MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B06AX05 B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AX Other hematological agents
Discover more medicines within B06AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
LT Valstybinė vaistų kontrolės tarnyba 1098907
US FDA, National Drug Code 51167-290

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.